AU2003299732A1 - Vectors for inducible rna interference - Google Patents

Vectors for inducible rna interference

Info

Publication number: AU2003299732A1
Authority: AU; Australia
Prior art keywords: vectors; rna interference; inducible rna; inducible; interference
Prior art date: 2002-12-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003299732A

Other languages

English (en)

Other versions

AU2003299732A8 (en

Inventor

Bijan Etemad-Moghadam

Joerg Heyer

Ronan C. O'hagan

William Rideout

William Winston

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aveo Pharmaceuticals Inc

Original Assignee

Genpath Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-18

Filing date

2003-12-18

Publication date

2004-07-14

2003-12-18 Application filed by Genpath Pharmaceuticals Inc filed Critical Genpath Pharmaceuticals Inc

2004-07-14 Publication of AU2003299732A8 publication Critical patent/AU2003299732A8/xx

2004-07-14 Publication of AU2003299732A1 publication Critical patent/AU2003299732A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003299732A 2002-12-18 2003-12-18 Vectors for inducible rna interference Abandoned AU2003299732A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US43485602P	2002-12-18	2002-12-18
US60/434,856		2002-12-18
US49931303P	2003-08-28	2003-08-28
US60/499,313		2003-08-28
PCT/US2003/040548 WO2004056964A2 (fr)	2002-12-18	2003-12-18	Vecteurs pour l'interference arn inductible

Publications (2)

Publication Number	Publication Date
AU2003299732A8 AU2003299732A8 (en)	2004-07-14
AU2003299732A1 true AU2003299732A1 (en)	2004-07-14

Family

ID=32685340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003299732A Abandoned AU2003299732A1 (en)	2002-12-18	2003-12-18	Vectors for inducible rna interference

Country Status (2)

Country	Link
AU (1)	AU2003299732A1 (fr)
WO (1)	WO2004056964A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8198077B2 (en)	2003-01-17	2012-06-12	Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.	Inducible small RNA expression constructs for targeted gene silencing
FR2877674A1 (fr) *	2004-11-08	2006-05-12	Genoxay Sa	Animaux modeles comprenant au moins un transgene et une sequence permettant l'expression controlee d'un rna interferant avec ledit transgene
NZ556635A (en) *	2004-12-22	2010-11-26	Genentech Inc	Method for producing soluble multi-membrane-spanning proteins
US20090210955A1 (en) *	2005-06-09	2009-08-20	Artemis Pharmaceuticals Gmbh	Shrna and sirna expression in a living organism under control of a codon-optimized repressor gene
EP1731607A1 (fr) *	2005-06-09	2006-12-13	ARTEMIS Pharmaceuticals GmbH	Expression au sein d'un organisme vivant de shRNA et siRNA sous le contrôle d'un gène represseur de tétracycline à codons optimisés
US20080220471A1 (en) *	2005-07-27	2008-09-11	Genentech, Inc.	Vectors and Methods Using Same
US20070113295A1 (en) *	2005-09-23	2007-05-17	California Institute Of Technology	Gene blocking method
GB0602173D0 (en)	2006-02-03	2006-03-15	Avecia Ltd	Expression system
EP3219799A1 (fr) *	2016-03-17	2017-09-20	IMBA-Institut für Molekulare Biotechnologie GmbH	Expression sgrna crispr conditionnelle
CN110540995B (zh) *	2018-05-28	2023-01-10	南京农业大学	一种降低肌球蛋白-5蛋白及其在氰基丙烯酸酯类药物抗性治理中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994004672A1 (fr) *	1992-08-26	1994-03-03	Dnx Corp.	Systeme de regulation binaire, a mediation par un represseur, qui utilise la tetracydine pour controler l'expression de genes chez les animaux transgeniques
AU2002343792A1 (en) *	2001-11-28	2003-06-10	Center For Advanced Science And Technology Incubation, Ltd.	siRNA EXPRESSION SYSTEM AND PROCESS FOR PRODUCING FUNCTIONAL GENE-KNOCKDOWN CELLS AND THE LIKE USING THE SAME
AU2003228301A1 (en) *	2002-03-06	2003-09-22	Rigel Pharmaceuticals, Inc.	Novel method for delivery and intracellular synthesis of sirna molecules
EP1554386A2 (fr) *	2002-07-24	2005-07-20	Immusol Incorporated	Systeme a un seul promoteur pour la production de cassettes d'expression d'arnsi et genotheque d'expression reposant sur l'utilisation d'un lieur en epingle a cheveux d'amorce de polymerase

2003
- 2003-12-18 WO PCT/US2003/040548 patent/WO2004056964A2/fr not_active Application Discontinuation
- 2003-12-18 AU AU2003299732A patent/AU2003299732A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004056964A3 (fr)	2004-10-14
WO2004056964A2 (fr)	2004-07-08
AU2003299732A8 (en)	2004-07-14

Publication	Publication Date	Title
AU2003295539A1 (en)	2004-06-15	Allele-targeted rna interference
PL378267A1 (pl)	2006-03-20	Interferencja RNA
AU2003299531A1 (en)	2004-06-07	Compounds for modulating rna interference
AU2003293409A1 (en)	2004-06-30	Method for discovering neurogenic agents
AU2002312114A1 (en)	2002-12-09	Sequencing by proxy
AU2003237686A1 (en)	2003-12-12	Rna interference mediating small rna molecules
AU2003216337A1 (en)	2003-09-16	Firewall
AU2002352241A1 (en)	2003-07-15	Titration method
AU2003278695A1 (en)	2004-02-02	Nucleic acid vectors
AU2003269787A1 (en)	2004-05-13	Mobile resemblance estimation
AU2003299732A1 (en)	2004-07-14	Vectors for inducible rna interference
AU2003205259A1 (en)	2003-09-02	Process for finish-abrading optical-fiber-connector end-surface
AU2002360394A1 (en)	2003-06-10	Facilitation of rna interference
AU2002361852A1 (en)	2003-07-15	Potassium fluoroionophore
AU2003271883A1 (en)	2004-04-23	Vector system
AU2002953066A0 (en)	2002-12-19	Reel
AU2003294705A1 (en)	2004-06-07	NtSM GENE
AU2003230655A1 (en)	2003-09-29	Coated pelletized shortening
AU2003244993A1 (en)	2004-01-06	Iron
AU2003208820A1 (en)	2003-09-09	Molluscicide
AU2002331281A1 (en)	2003-02-17	New uses for 2-amino-2-propane-1,3-diols
AU2003255307A1 (en)	2004-03-19	Arylamides
AU2003253447A1 (en)	2004-02-23	Expression vectors
AU2003242061A1 (en)	2003-12-19	Method for fast frequency estimation by means of the rls method
AU2002229907A1 (en)	2002-08-19	Improved electrophoretic deposition

Legal Events

Date	Code	Title	Description
2005-09-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase